Israel's Wize Pharma Inc. implemented a 1-for-24 reverse split of its common stock, effective March 5.
The biopharmaceutical company said the split will reduce the number of issued and outstanding common stock to about 4.3 million from about 104 million.
Wize Pharma's split-adjusted stock will trade under the ticker symbol WIZPD for 20 days, after which time the D will be removed and the stock will resume trading under the ticker symbol WIZP.
